Adam C Mirando

7PUBLICATIONS
16CO-AUTHORS
Gene and molecular therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Optical technologyMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 10, 2026
Suprachoroidal Delivery of Anti-Angiogenic Peptide Microparticles Enables Sustained Activity with Favorable Ocular Safety.

|Sep 02, 2025
Oncolytic peptide NF27 effectively inhibits tumor growth and eradicates tumors in multiple cancer types.

Natsuki Furukawa, Alex R Chao, Wendy Yang

|Apr 02, 2024
Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth.

Natsuki Furukawa, Wendy Yang, Alex R Chao

|Sep 14, 2020
Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide.

Adam C Mirando, Akash Patil, Christine I Rafie

|Jul 26, 2020
Suppression of Ocular Vascular Inflammation through Peptide-Mediated Activation of Angiopoietin-Tie2 Signaling.

Adam C Mirando, Raquel Lima E Silva, Zenny Chu

|Nov 19, 2019
A mechanistic integrative computational model of macrophage polarization: Implications in human pathophysiology.

Chen Zhao, Adam C Mirando, Richard J Sové

Pageof 2

Frequent Collaborators

4 joint publications

Aleksander S Popel

3 joint publications

Akash Patil

3 joint publications

Niranjan B Pandey

2 joint publications

Natsuki Furukawa